SOMERSET, N.J., Dec. 11, 2017 -- Franklin Family Eyecare Now offers patients access to the optomap as part of a comprehensive eye exam. The optomap is a 200 degree digital image of the retina. This is much wider than a traditional 45 degree image.
“I am extremely pleased to offer this technology to my patients,” said Dr. Josephine. “Most patients feel they should only be examined when they need a change in prescription. In reality, one of the most important parts of the examination is determining the health of the retina. The optomap provides us with a permanent digital image which I can manipulate and magnify to have the most comprehensive view of the back of the eye in order to better and more effectively discover abnormalities that may be present.”
The optomap non-invasively captures an instantaneous, ultra-widefield digital image of the retina, revealing important information for the comprehensive evaluation of systemic and ocular health. The image, which is captured in a quarter of a second, enhances clinical care, patient satisfaction, and practice efficiency. It is performed quickly and easily which enables practitioners to spend more time diagnosing and educating rather than gathering information. An optomap is performed as an initial step in a comprehensive eye exam. An optomap image provides the practitioner with a tool to help discover retinal disease, and assist in the diagnosis of eye conditions – and potentially other health conditions – early. It also enables the practitioner to effectively determine the next course of action.
Early detection of any retinal abnormality may lead to earlier and safer treatments and in many cases prevent vision loss. An optomap should be performed annually regardless of symptoms, thereby allowing doctors to observe subtle changes occurring as their patients age.
Since its inception in 1999, millions of optomap images have been conducted worldwide, aiding in the detection and diagnosis of serious eye conditions such as diabetic retinopathy, retinal detachments, macular degeneration, and other pathologies like melanomas.
About Optos
Optos has the vision to be The Retina Company. They aim to be recognized as a leading provider of devices and solutions to eyecare professionals for improved patient care. Optos' core devices produce ultra-widefield, high-resolution digital images (optomap®) of approximately 82% of the retina, something no other device is capable of doing in a single image.
For more information please visit www.optos.com.
FRANKLIN FAMILY EYECARE is a private, Dr. owned Optometry practice located in SOMERSET, NJ. They are committed to providing the highest standard of health care with personalized service and quality products in a friendly and caring atmosphere; improving quality of life and overall health through education, prevention, and early detection by utilizing cutting-edge technologies.
Patients: For more information or to schedule an optomap exam, please contact Dr. Josephine at FRANKLIN FAMILY EYECARE. 732-412-7328


Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Washington Post Publisher Will Lewis Steps Down After Layoffs
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



